Environmental pollution: A tangible risk for NAFLD pathogenesis

International Journal of Molecular Sciences

Volumn 14, Issue 11, 2013, Pages 22052-22066

  Arciello, Mario ^a   Gori, Manuele ^a,b   Maggio, Roberta ^a   Barbaro, Barbara ^a   Tarocchi, Mirko ^c   Galli, Andrea ^c   Balsano, Clara ^a,d  

^a Laboratory of Molecular Virology and Oncology Francesco Balsano Foundation   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d CNR   (Italy)

Author keywords

Chemicals; Contaminants; Endocrine disruptors; Environment; Liver; Metals; NAFLD; Nonalcoholic steatohepatitis (NASH); Particulate matter; Pollution

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ADIPONECTIN; ARSENIC; BENDIOCARB; CHLOROFORM; CYTOKINE; ENDOCRINE DISRUPTOR; GLUCOSE; GLYCOGEN; HERBICIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUSTRIAL CHEMICAL; LEAD; MERCURY; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PESTICIDE; SOLVENT; STRESS ACTIVATED PROTEIN KINASE 1; TETRACHLOROETHYLENE; TOLL LIKE RECEPTOR 4; TRICHLOROETHYLENE;

ADIPOGENESIS; AIR POLLUTION; ATMOSPHERIC DIFFUSION; ATMOSPHERIC DISPERSION; CARCINOGENICITY; CARDIOVASCULAR DISEASE; CELL ACTIVATION; CHEMICAL ANALYSIS; COMBUSTION; DISEASE EXACERBATION; ENVIRONMENTAL FACTOR; ENVIRONMENTAL IMPACT; ENZYME ACTIVATION; EXHAUST GAS; FATTY LIVER; FOOD CONTAMINATION; FOOD PACKAGING; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLYCOGEN LIVER LEVEL; HEALTH HAZARD; HEPATITIS; HISTOPATHOLOGY; HUMAN; INDUSTRIALIZATION; KUPFFER CELL; LIFESTYLE MODIFICATION; LIPID METABOLISM; LIVER DISEASE; LIVER FUNCTION; METABOLIC DISORDER; MOLECULAR MECHANICS; NONALCOHOLIC FATTY LIVER; NONHUMAN; PARTICLE SIZE; PARTICULATE MATTER; PATHOGENESIS; PNEUMONIA; POLLUTANT; POLLUTION; PREVALENCE; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; PROTEIN SYNTHESIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SAND; SMOKE; SUSPENDED PARTICULATE MATTER; TECHNOLOGY; VAPOR; WATER POLLUTANT;

ENVIRONMENTAL POLLUTANTS; ENVIRONMENTAL POLLUTION; FATTY LIVER; HUMANS; LIVER;

EID: 84887339631     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms141122052     Document Type: Review

References (84)

1. Marchesini, G.; Bugianesi, E.; Forlani, G.; Cerrelli, F.; Lenzi, M.; Manini, R.; Natale, S.; Vanni, E.; Villanova, N.; Melchionda, N.; et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003, 37, 917-923.
2. Schaffner, F.; Thaler, H. Nonalcoholic fatty liver disease. Prog. Liver Dis. 1986, 8, 283-298.
3. Angulo, P. Nonalcoholic fatty liver disease. N. Engl. J. Med. 2002, 346, 1221-1231.
4. Starley, B.Q.; Calcagno, C.J.; Harrison, S.A. Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection. Hepatology 2010, 51, 1820-1832.
5. Day, C.P.; James, O.F. Steatohepatitis: A tale of two "hits"? Gastroenterology 1998, 114, 842-845.
6. Marra, F.; Gastaldelli, A.; Svegliati Baroni, G.; Tell, G.; Tiribelli, C. Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. Trends Mol. Med. 2008, 14, 72-81.
7. Tan, H.-H.; Fiel, M.I.; Sun, Q.; Guo, J.; Gordon, R.E.; Chen, L.C.; Friedman, S.L.; Odin, J.A.; Allina, J. Kupffer cell activation by ambient air particulate matter exposure may exacerbate non-alcoholic fatty liver disease. J. Immunotoxicol. 2009, 6, 266-275.
8. Zheng, Z.; Xu, X.; Zhang, X.; Wang, A.; Zhang, C.; Hüttemann, M.; Grossman, L.I.; Chen, L.C.; Rajagopalan, S.; Sun, Q.; et al. Exposure to ambient particulate matter induces a NASH-like phenotype and impairs hepatic glucose metabolism in an animal model. J. Hepatol. 2013, 58, 148-154.
9. Hyder, O.; Chung, M.; Cosgrove, D.; Herman, J.M.; Li, Z.; Firoozmand, A.; Gurakar, A.; Koteish, A.; Pawlik, T.M. Cadmium exposure and liver disease among US adults. J. Gastrointest. Surg. 2013, 17, 1265-1273.
10. Polyzos, S.A.; Kountouras, J.; Deretzi, G.; Zavos, C.; Mantzoros, C.S. The emerging role of endocrine disruptors in pathogenesis of insulin resistance: A concept implicating nonalcoholic fatty liver disease. Curr. Mol. Med. 2012, 12, 68-82.
11. Tomaru, M.; Takano, H.; Inoue, K.; Yanagisawa, R.; Osakabe, N.; Yasuda. A.; Shimada, A.; Kato, Y.; Uematsu, H. Pulmonary exposure to diesel exhaust particles enhances fatty change of the liver in obese diabetic mice. Int. J. Mol. Med. 2007, 19, 17-22.
12. Cave, M.; Appana, S.; Patel, M.; Falkner, K.C.; McClain, C.J.; Brock, G. Polychlorinated biphenyls, lead, and mercury are associated with liver disease in American adults: NHANES 2003-2004. Environ. Health Perspect. 2010, 118, 1735-1742.
13. Kelishadi, R.; Mirghaffari, N.; Poursafa, P.; Gidding, S.S. Lifestyle and environmental factors associated with inflammation, oxidative stress and insulin resistance in children. Atherosclerosis 2009, 203, 311-319.
14. Sun, Q.; Yue, P.; Deiuliis, J.A.; Lumeng, C.N.; Kampfrath, T.; Mikolaj, M.B.; Cai, Y.; Ostrowski, M.C.; Lu, B.; Parthasarathy, S.; et al. Ambient air pollution exaggerates adipose inflammation and insulin resistance in a mouse model of diet-induced obesity. Circulation 2009, 119, 538-546.
15. Chen, J.C.; Schwartz, J. Metabolic syndrome and inflammatory responses to long-term particulate air pollutants. Environ. Health Perspect. 2008, 116, 612-617.
16. Tarantino, G.; Capone, D.; Finelli, C. Exposure to ambient air particulate matter and non-alcoholic fatty liver disease. World J. Gastroenterol. 2013, 19, 3951-3956.
17. Wahlang, B.; Beier, J.I.; Cllair, H.B.; Bellis-Jones, H.J.; Falkner, K.C.; McClain, C.J.; Cave, M.C. Toxicant-associated steatohepatitis. Toxicol. Pathol. 2013, 41, 343-360.
18. Schwingel, P.A.; Cotrim, H.P.; Salles, B.R.; Almeida, C.E.; dos Santos, C.R., Jr.; Nachef, B.; Andrade, A.R.; Zoppi, C.C. Anabolic-androgenic steroids: A possible new risk factor of toxicant-associated fatty liver disease. Liver Int. 2011, 31, 348-353.
19. Cave, M.; Deaciuc, I.; Mendez, C.; Song, Z.; Joshi-Barve, S.; Barve, S.; McClain, C. Nonalcoholic fatty liver disease: Predisposing factors and the role of nutrition. J. Nutr. Biochem. 2007, 18, 184-195.
20. Cave, M.; Falkner, K.C.; Ray, M.; Joshi-Barve, S.; Brock, G.; Khan, R.; Bon Homme, M.; McClain, C.J. Toxicant-associated steatohepatitis in vinyl chloride workers. Hepatology 2010, 51, 474-481.
21. Fuentes, M.; Song, H.R.; Ghosh, S.K.; Holland, D.M.; Davis, J.M. Spatial association between speciated fine particles and mortality. Biometrics 2006, 62, 855-863.
22. Dockery, D.W. Health effects of particulate air pollution. Ann. Epidemiol. 2009, 19, 257-263.
23. Kramer, U.; Herder, C.; Sugiri, D.; Strassburger, K.; Schikowski, T.; Ranft, U.; Rathmann, W. Traffic-related air pollution and incident type 2 diabetes: Results from the SALIA cohort study. Environ. Health Perspect. 2010, 118, 1273-1279.
24. Pearson, J.F.; Bachireddy, C.; Shyamprasad, S.; Goldfine, A.B.; Brownstein, J.S. Association between fine particulate matter and diabetes prevalence in the US. Diabetes Care 2010, 33, 2196-2201.
25. Brook, R.D.; Jerrett, M.; Brook, J.R.; Bard, R.L.; Finkelstein, M.M. The relationship between diabetes mellitus and traffic-related air pollution. J. Occup. Environ. Med. 2008, 50, 32-38.
26. Xu, X.; Yavar, Z.; Verdin, M.; Ying, Z.; Mihai, G.; Kampfrath, T.; Wang, A.; Zhong, M.; Lippmann, M.; Chen, L.C.; et al. Effect of early particulate air pollution exposure on obesity in mice: Role of p47phox. Arterioscler. Thromb. Vasc. Biol. 2010, 30, 2518-2527.
27. Laing, S.; Wang, G.; Briazova, T.; Zhang, C.; Wang, A.; Zheng, Z.; Gow, A.; Chen, A.F.; Rajagopalan S.; Chen, L.C.; et al. Airborne particulate matter selectively activates endoplasmic reticulum stress response in the lung and liver tissues. Am. J. Physiol. Cell Physiol. 2010, 299, C736-C749.
28. Feige, J.N.; Gelman, L.; Michalik, L.; Desvergne, B.; Wahli, W. From molecular action to physiological outputs: Peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. Prog. Lipid Res. 2006, 45, 120-159.
29. Galli, A.; Crabb, D.W.; Ceni, E.; Salzano, R.; Mello, T.; Svegliati-Baroni, G.; Ridolfi, F.; Trozzi, L.; Surrenti, C.; Casini, A. Antidiabetic thiazolidinediones, inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro. Gastroenterology 2002, 122, 1924-1940.
30. Heal, M.R.; Kumar, P.; Harrison, R.M. Particles, air quality, policy and health. Chem. Soc. Rev. 2012, 41, 6606-6630.
31. Furuyama, A.; Kanno, S.; Kobayashi, T.; Hirano, S. Extrapulmonary translocation of intratracheally instilled fine and ultrafine particles via direct and alveolar macrophage-associated routes. Arch. Toxicol. 2009, 83, 429-437.
32. Stanek, L.W.; Sacks, J.D.; Dutton, S.J.; Dubois, J.J.B. Attributing health effects to apportioned components and sources of particulate matter: An evaluation of collective results. Atmos. Environ. 2011, 45, 5655-5663.
33. Gauderman, W.J.; Avol, E.; Gilliland, F.; Vora, H.; Thomas, D.; Berhane, K.; McConnell, R.; Kuenzli, N.; Lurmann, F.; Rappaport, E.; et al. The effect of air pollution on lung development from 10 to 18 years of age. N. Engl. J. Med. 2004, 351, 1057-1067.
34. McCreanor, J.; Cullinan, P.; Nieuwenhuijsen, M.J.; Stewart-Evans, J.; Malliarou, E.; Jarup, L.; Harrington, R.; Svartengren, M.; Han, I.K.; Ohman-Strickland, P.; et al. Respiratory effects of exposure to diesel traffic in persons with asthma. N. Engl. J. Med. 2007, 357, 2348-2358.
35. Patel, M.M.; Chillrud, S.N.; Correa, J.C.; Hazi, Y.; Feinberg, M.; Deepti, K.C.; Swati, P.; Ross, J.M.; Levy, D.; Kinney, P.L. Traffic-related particulate matter and acuterespiratory symptoms among New York City area adolescents. Environ. Health Perspect. 2010, 118, 1338-1343.
36. Strak, M.; Janssen, N.A.H.; Godri, K.J.; Gosens, I.; Mudway, I.S.; Cassee, F.R.; Lebret, E.; Kelly, F.J.; Harrison, R.M.; Brunekreef, B.; et al. Respiratory healtheffects of airborne particulate matter: The role of particle size, composition, andoxidative potential-The RAPTES project. Environ. Health Perspect. 2012, 120, 1183-1189.
37. Hong, Y.C.; Hwang, S.S.; Kim, J.H.; Lee, K.H.; Lee, H.J.; Lee, K.H.; Yu, S.D.; Kim, D.S. Metals in particulate pollutants affect peak expiratory flow of schoolchildren. Environ. Health Perspect. 2007, 115, 430-434.
38. Hong, Y.C.; Pan, X.C.; Kim, S.Y.; Park, K.; Park, E.J.; Jin, X.; Yi, S.M.; Kim, Y.H.; Park, C.H.; Song, S.; et al. Asian Dust Storm and pulmonary function of school children in Seoul. Sci. Total Environ. 2010, 408, 754-759.
39. Wu, S.; Deng, F.; Hao, Y.; Shima, M.; Wang, X.; Zheng, C.; Wei, H.; Lv, H.; Lu, X.; Huang, J.; et al. Chemical constituents of fine particulate air pollution and pulmonary function in healthy adults: The Healthy Volunteer Natural Relocation study. J. Hazard. Mater. 2013, 260, 183-191.
40. Liggi, M.; Murgia, D.; Civolani, A.; Demelia, E.; Sorbello, O.; Demelia, L. The relationship between copper and steatosis in Wilson's disease. Clin. Res. Hepatol. Gastroenterol. 2013, 37, 36-40.
41. Nagasaka, H.; Miida, T.; Inui, A.; Inoue, I.; Tsukahara, H.; Komatsu, H.; Hiejima, E.; Fujisawa, T.; Yorifuji, T.; Hiranao, K.; et al. Fatty liver and anti-oxidant enzyme activities along with peroxisome proliferator-activated receptors γ and α expressions in the liver of Wilson's disease. Mol. Genet. MeTab. 2012, 107, 542-547.
42. Kavlock, R.J.; Daston, G.P.; DeRosa, C.; Fenner-Crisp, P.; Gray, L.E.; Kaattari, S.; Lucier, G.; Luster, M.; Mac, M.J.; Maczka, C.; et al. Research needs for the risk assessment of health and environmental effects of endocrine disruptors: A report of the U.S. EPA-sponsored workshop. Environ. Health Perspect. 1996, 104, 715-740.
43. Ding, D.; Xu, L.; Fang, H.; Hong, H.; Perkins, R.; Harris, S.; Bearden, E.D.; Shi, L.; Tong, W. The EDKB: An established knowledge base for endocrine disrupting chemicals. BMC Bioinforma. 2010, 11, S5:1-S5:7.
44. Matsubara, T.; Tanaka, N.; Krausz, K.W.; Manna, S.K.; Kang, D.W.; Anderson, E.R.; Luecke, H.; Patterson, A.D.; Shah, Y.M.; Gonzalez, F.J. Metabolomics identifies an inflammatory cascade involved in dioxin-and diet-induced steatohepatitis. Cell Metab. 2012, 16, 634-644.
45. Vancova, O.; Ulicna, O.; Horecky, J.; Zeljenkova, D.; Wimmerova, S.; Trnovec, T. Liver steatosis and disorders of mitochondrial oxidative phosphorylation after experimental administration of simazine. Bratisl. Lek. Listy 2000, 101, 423-428.
46. Allender, W.J.; Glastonbury, J.W. Simazine toxicosis in sheep. Vet. Hum. Toxicol. 1992, 34, 422-423.
47. Lim, S.; Ahn, S.Y.; Song, I.C.; Chung, M.H.; Jang, H.C.; Park, K.S.; Lee, K.U.; Pak, Y.K.; Lee, H.K. Chronic exposure to the herbicide, atrazine, causes mitochondrial dysfunction and insulin resistance. PLoS One 2009, 4, e5186.
48. Petrovova, E.; Purzyc, H.; Mazensky, D.; Luptakova, L.; Torma, N.; Sopoliga, I.; Sedmera, D. Morphometric alterations, steatosis, fibrosis and active caspase-3 detection in carbamate bendiocarb treated rabbit liver. Environ. Toxicol. 2013, doi:10.1002/tox.21887.
49. Baconi, D.L.; Bârcǎ, M.; Manda, G.; Ciobanu, A.M.; Bǎlǎlǎu, C. Investigation of the toxicity of some organophosphorus pesticides in a repeated dose study in rats. Rom. J. Morphol. Embryol. 2013, 54, 349-356.
50. Crépet, A.; Héraud, F.; Béchaux, C.; Gouze, M.E.; Pierlot, S.; Fastier, A.; Leblanc, J.C.; le Hégarat, L.; Takakura, N.; Fessard, V.; et al. The PERICLES research program: An integrated approach to characterize the combined effects of mixtures of pesticide residues to which the French population is exposed. Toxicology 2013, doi.10.1016/j.tox.2013.04.005.
51. He, J.; Gao, J.; Xu, M.; Ren, S.; Stefanovic-Racic, M.; O'Doherty, R.M.; Xie, W. PXR ablation alleviates diet-induced and genetic obesity and insulin resistance in mice. Diabetes 2013, 62, 1876-1887.
52. Cheng, J.; Krausz, K.W.; Tanaka, N.; Gonzalez, F.J. Chronic exposure to rifaximin causes hepatic steatosis in pregnane X receptor-humanized mice. Toxicol. Sci. 2012, 129, 456-468.
53. Viollet, B.; Guigas, B.; Leclerc, J.; Hebrard, S.; Lantier, L.; Mounier, R.; Andreelli, F.; Foretz, M. AMP-activated protein kinase in the regulation of hepatic energy metabolism: From physiology to therapeutic perspectives. Acta Physiol. (Oxf.) 2009, 196, 81-98.
54. Das, K.; Das, K.; Mukherjee, P.S.; Ghosh, A.; Ghosh, S.; Mridha, A.R.; Dhibar, T.; Bhattacharya, B.; Bhattacharya, D.; Manna, B.; et al. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease. Hepatology 2010, 51, 1593-1602.
55. Mokdad, A.H.; Ford, E.S.; Bowman, B.A.; Dietz, W.H.; Vinicor, F.; Bales, V.S.; Marks, J.S. Prevalence of obesity, diabetes, and obesity-related health risk factors. J. Am. Med. Assoc. 2001, 289, 76-79.
56. Welch, A.H.; Watkins, S.A.; Helsel, D.R.; Focazio, M.J. Arsenic in ground-water resources of the United States. 2000. U.S. Geological Survey Fact Sheet 063-00. Available online: http://pubs.usgs.gov/fs/old.2000/fs063-00/fs063-00.html (accessed on 31 July 2013).
57. Verheij, J.; Voortman, J.; van Nieuwkerk, C.M.; Jarbandhan, S.V.; Mulder, C.J.; Bloemena, E. Hepatic morphopathologic findings of lead poisoning in a drug addict: A case report. J. Gastrointest. Liver Dis. 2009, 18, 225-227.
58. Satarug, S.; Moore, M.R. Adverse health effects of chronic exposure to low-level cadmium in foodstuffs and cigarette smoke. Environ. Health Perspect. 2004, 112, 1099-1103.
59. Schwartz, G.G.; Il'yasova, D.; Ivanova, A. Urinary cadmium, impaired fasting glucose, and diabetes in the NHANES III. Diabetes Care 2003, 26, 468-470.
60. Tuñón, M.J.; Alvarez, M.; Culebras, J.M.; González-Gallego, J. An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure. World J. Gastroenterol. 2009, 15, 3086-3098.
61. Shi, X.; Wahlang, B.; Wei, X.; Yin, X.; Falkner, K.C.; Prough, R.A.; Kim, S.H.; Mueller, E.G.; McClain, C.J.; Cave, M.; et al. Metabolomic analysis of the effects of polychlorinated biphenyls in non-alcoholic fatty liver disease. J. Proteome Res. 2012, 11, 3805-3815.
62. Fang, Z.Z.; Krausz, K.W.; Tanaka, N.; Li, F.; Qu, A.; Idle, J.R.; Gonzalez, F.J. Metabolomics reveals trichloroacetate as a major contributor to trichloroethylene-induced metabolic alterations in mouse urine and serum. Arch. Toxicol. 2013, 87, 1975-1987.
63. Bakke, B.; Stewart, P.A.; Waters, M.A. Uses of and exposure to trichloroethylene in US industry: A systemic literature review. J. Occup. Environ. Hyg. 2007, 4, 375-390.
64. Candura, S.M.; Faustman, E.M. Trichloroethylene: Toxicology and health hazards. Giornale Italiano di Medicina del Lavoro 1991, 13, 17-25.
65. Pesch, B.; Haerting, J.; Ranft, U.; Klimpel, A.; Oelschlagel, B.; Schill, W. Occupational risk factors for renal cell carcinoma: Agent-specific results from a case-control study in Germany, MURC Study Group. Multicenter urothelial and renal cancer study. Int. J. Epidemiol. 2000, 29, 1014-1024.
66. Wartenberg, D.; Reyner, D.; Scott, C.S. Trichloroethylene and cancer: Epidemiologic evidence. Environ. Health Perspect. 2000, 108, 161-176.
67. Ramdhan, D.H.; Kamijima, M.; Wang, D.; Ito, Y.; Naito, H.; Yanagiba, Y.; Hayashi, Y.; Tanaka, N.; Aoyama, T.; Gonzalez, F.J.; et al. Differential response to trichloroethylene-induced hepatosteatosis in wild-type and PPARα-humanized mice. Environ. Health Perspect. 2010, 118, 1557-1563.
68. Kumar, P.; Prasad, A.K.; Maji, B.K.; Mani, U.; Dutta, K.K. Hepatoxic alterations induced by inhalation of trichlorethylene (TCE) in rats. Biomed. Environ. Sci. 2001, 14, 325-332.
69. Liu, J. Clinical analysis of seven cases of trichloroethylene medicamentose-like dermatitis. Ind. Health 2009, 47, 685-688.
70. Li, Z.; Berk, M.; McIntyre, T.M.; Gores, G.J.; Feldstein, A.E. The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity. Hepatology 2008, 47, 1495-1503.
71. Pezzini, A.; Martini, A.M.; Gonzalez, D.P.; Cespedes, N.A.F. Nonalcoholic steatohepatitis by percloroetileno: Case report. Revista de Posgrado de la via Catedra de Medicina 2008, 179, 8-9.
72. Philip, B.K.; Mumtaz, M.M.; Latendresse, J.R.; Mehendale, H.M. Impact of repeated exposure on toxicity of perchloroethylene in Swiss Webster mice. Toxicology 2007, 232, 1-14.
73. Kylin, B.; Reichard, H.; Sumegi, I.; Yllner, S. Hepatotoxic effect of tri-and tetra-chlorethylene on mice. Nature 1962, 193, 395.
74. Thorpe, C.M.; Spence, A.A. Clinical evidence for delayed chloroform poisoning. Br. J. Anaesth. 1997, 79, 402-409.
75. Baranova, A.; Tran, T.P.; Birerdinc, A.; Younossi, Z.M. Systematic review: Association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease. Aliment. Pharmacol. Ther. 2011, 33, 801-814.
76. Ben-Jonathan, N.; Hugo, E.R.; Brandebourg, T.D. Effects of bisphenol A on adipokine release from human adipose tissue: Implications for the metabolic syndrome. Mol. Cell. Endocrinol. 2009, 304, 49-54.
77. Lim, S.; Cho, Y.M.; Park, K.S.; Lee, H.K. Persistent organic pollutants, mitochondrial dysfunction, and metabolic syndrome. Ann. N. Y. Acad. Sci. 2010, 1201, 166-176.
78. Hatch, E.E.; Nelson, J.W.; Stahlhut, R.W.; Webster, T.F. Association of endocrine disruptors and obesity: Perspectives from epidemiological studies. Int. J. Androl. 2010, 33, 324-332.
79. Grun, F.; Blumberg, B. Environmental obesogens: Organotins and endocrine disruption via nuclear receptor signaling. Endocrinology 2006, 147, 50-55.
80. Newbold, R.R.; Padilla-Banks, E.; Snyder, R.J.; Jefferson, W.N. Perinatal exposure to environmental estrogens and the development of obesity. Mol. Nutr. Food Res. 2007, 51, 912-917.
81. Kidani, T.; Kamei, S.; Miyawaki, J.; Aizawa, J.; Sakayama, K.; Masuno, H. Bisphenol A downregulates Akt signaling and inhibits adiponectin production and secretion in 3T3-L1 adipocytes. J. Atheroscler. Thromb. 2010, 17, 834-843.
82. Lang, I.A.; Galloway, T.S.; Scarlett A.; Henley, W.E.; Depledge, M.; Wallace, R.B.; Melzer, D. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. J. Am. Med. Assoc. 2008, 300, 1303-1310.
83. Hong, Y.C.; Park, E.Y.; Park, M.S.; Ko, J.A.; Oh, S.Y.; Kim, H.; Lee, K.H.; Leem, J.H.; Ha, E.H. Community level exposure to chemicals and oxidative stress in adult population. Toxicol. Lett. 2009, 184, 139-144.
84. Kandaraki, E.; Chatzigeorgiou, A.; Livadas, S.; Palioura, E.; Economou, F.; Koutsilieris, M.; Palimeri, S.; Panidis, D.; Diamanti-Kandarakis, E. Endocrine disruptors and polycystic ovary syndrome (PCOS): Elevated serum levels of bisphenol a in women with PCOS. J. Clin. Endocrinol. Metab. 2011, 96, 480-484.